peter

Peter Andersson

PhD Candidate in Psychiatry, Karolinska Institutet
As a licensed clinical psychologist working in forensic psychiatric care at one of Sweden’s largest forensic psychiatric facilities, I possess extensive hands-on experience in managing and treating individuals with severe mental illness. Currently pursuing my doctoral studies at Karolinska Institutet in clinical neuroscience, I am deeply invested in the field of adolescent mental health, particularly focusing on reducing suicide rates and enhancing recognition and access to evidence-based treatments for youth with severe mental illness. My research background primarily lies in psychiatric epidemiology and clinical trials, where I have contributed to advancing knowledge in adult psychiatric disorders. However, my recent focus has shifted towards understanding the importance of direct clinical approaches in addressing the mental health needs of adolescents. Drawing from my clinical expertise and research insights, I bring a unique perspective to the field, challenging notions of single therapy as the sole solution for severe mental illness. Recognizing the crucial role of medical treatment as a foundation for successful psychotherapeutic interventions in severely affected psychiatric patients, I aim to bridge the gap between various perspectives and contribute to the holistic and comprehensive care of individuals struggling with mental health challenges.

More from this expert

Suicide rarely happens in the absence of severe mental health problems. Research indicates that psychiatric disorders are prevalent in up to 90% of adolescents who die from suicide. In particular, what are known as affective disorders, such as major depressive disorder and bipolar disorder, are present in 44%-76% of cases.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.